Alembic

  • Market Cap: Small Cap
  • Industry: Realty
  • ISIN: INE426A01027
  • NSEID: ALEMBICLTD
  • BSEID: 506235
INR
79.65
-1.4 (-1.73%)
BSENSE

Mar 16

BSE+NSE Vol: 4.57 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.57 lacs (44.49%) Volume

Shareholding (Dec 2025)

FII

1.28%

Held by 42 FIIs

DII

0.05%

Held by 0 DIIs

Promoter

70.88%

When is the next results date for Alembic?

06-Jun-2025

No Upcoming Board Meetings

What is the bonus history of the Alembic?

06-Jun-2025

Alembic Ltd had a bonus issue of 1:1 announced on September 27, 2013, with a record date of September 30, 2013, allowing shareholders to double their holdings by receiving an additional share for each share held.

Alembic Ltd has a bonus history that includes a 1:1 bonus issue announced with an ex-date of September 27, 2013. The record date for this bonus was September 30, 2013. This means that for every share held, shareholders received an additional share, effectively doubling their holdings at that time.

View full answer

Has Alembic declared dividend?

06-Jun-2025

Yes, Alembic Ltd has declared a dividend of 120%, amounting to ₹2.4 per share, with an ex-date of August 5, 2024. The company has shown strong long-term performance, particularly with a total return of 116.15% over the past five years.

Alembic Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 120%<BR>- Amount per share: 2.4<BR>- Ex-date: 05 Aug 24<BR><BR>Dividend Yield: 2.25%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -18.81%, with a dividend return of 0%, resulting in a total return of -18.81%.<BR><BR>For the 1-year period, the price return was 14.5%, the dividend return was 2.33%, leading to a total return of 16.83%.<BR><BR>Over the 2-year period, the price return was 63.92%, with a dividend return of 6.28%, culminating in a total return of 70.2%.<BR><BR>In the 3-year period, the price return was 63.4%, the dividend return was 10.83%, which resulted in a total return of 74.23%.<BR><BR>For the 4-year period, the price return was -10.93%, with a dividend return of 5.17%, leading to a total return of -5.76%.<BR><BR>In the 5-year period, the price return was 107.05%, the dividend return was 9.10%, resulting in a total return of 116.15%.<BR><BR>Overall, Alembic Ltd has declared a significant dividend of 120%, and while the total returns vary across different periods, the company has shown strong performance over the longer term, particularly in the 5-year period.

View full answer

Is Alembic overvalued or undervalued?

09-Jun-2025

As of January 29, 2021, Alembic is considered very expensive and overvalued, with a PE ratio of 9.24, an EV to EBITDA of 30.14, and a year-to-date stock decline of 14.93%, indicating that its valuation does not align with industry standards despite comparable PE ratios to peers.

As of 29 January 2021, Alembic's valuation grade has moved from risky to very expensive, indicating a significant shift in its perceived value. The company is currently overvalued based on its financial metrics. Key ratios include a PE ratio of 9.24, an EV to EBITDA of 30.14, and a PEG ratio of 0.59, which suggest that while the earnings are relatively low compared to the price, the growth expectations are not sufficiently high to justify the current valuation.<BR><BR>When compared to peers in the realty sector, Alembic's PE ratio is on par with its competitors, but its EV to EBITDA ratio is notably high, indicating potential overvaluation. For instance, if we consider similar companies, they may have lower EV to EBITDA ratios, which could suggest that Alembic's pricing does not align with industry standards. Additionally, Alembic's recent stock performance shows a decline of 14.93% year-to-date, contrasting with a 5.60% rise in the Sensex, further reinforcing the notion that the stock may be overvalued in the current market environment.

View full answer

Who are the peers of the Alembic?

16-Jul-2025

Alembic's peers include Ajmera Realty, Kolte Patil Dev., EFC (I), Ashiana Housing, Arvind SmartSp., AGI Infra, Unitech, Omaxe, and Elpro Internatio. In terms of performance, Alembic has a 1-year return of -21.16%, better than Ashiana Housing's -22.34%.

Peers: The peers of Alembic are Ajmera Realty, Kolte Patil Dev., EFC (I), Ashiana Housing, Arvind SmartSp., AGI Infra, Unitech, Omaxe, and Elpro Internatio.<BR><BR>Quality Snapshot: Excellent management risk is observed at Ashiana Housing, while Average management risk is found at Ajmera Realty, Kolte Patil Dev., EFC (I), Alembic, Arvind SmartSp., AGI Infra, and Elpro Internatio, and the rest. Growth is Excellent at EFC (I), Good at Alembic and Elpro Internatio, and Below Average at Ajmera Realty, Kolte Patil Dev., Ashiana Housing, Arvind SmartSp., Unitech, and Omaxe, and the rest. Capital Structure is Excellent at Ashiana Housing and Alembic, Good at Arvind SmartSp. and AGI Infra, and Below Average at Ajmera Realty, Kolte Patil Dev., EFC (I), Unitech, Omaxe, and Elpro Internatio, and the rest.<BR><BR>Return Snapshot: AGI Infra has the highest 1-year return at 132.12%, while Ashiana Housing has the lowest at -22.34%. Alembic's 1-year return is -21.16%, which is slightly better than Ashiana Housing's. Additionally, the six-month return is negative for Alembic, Ashiana Housing, Arvind SmartSp., Unitech, and Elpro Internatio.

View full answer

Who are in the management team of Alembic?

16-Jul-2025

As of March 2023, the management team of Alembic includes Chirayu R Amin (Chairman), Malika C Amin (Managing Director & CEO), and several directors, including independent members. They oversee the company's operations and strategic direction.

As of March 2023, the management team of Alembic includes the following members:<BR><BR>1. Chirayu R Amin - Chairman (Non-Executive)<BR>2. Malika C Amin - Managing Director & CEO<BR>3. C P Buch - Independent Director<BR>4. Udit Amin - Director<BR>5. Abhijit Joshi - Director<BR>6. Sameer Khera - Independent Director<BR>7. Drigesh Mittal - Company Secretary & Compliance Officer<BR>8. Rati Desai - Independent Director<BR>9. Mayank Amin - Independent Director<BR>10. Girish Hirode - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

View full answer

What does Alembic do?

17-Jul-2025

Alembic Ltd is a manufacturer of bulk drugs and pharmaceuticals for human and animal healthcare, with a market cap of INR 3,083 Cr. As of March 2025, it reported net sales of 603 Cr and a net profit of 684 Cr, with a P/E ratio of 10.00.

Overview:<BR>Alembic Ltd is a manufacturer of bulk drugs and pharmaceuticals formulations in human and animal healthcare, operating in the Realty industry within the Small Cap market-cap bracket.<BR><BR>History:<BR>Alembic Ltd has a long-standing presence in the pharmaceutical sector, with operations primarily focused on the manufacture of bulk drugs and real estate. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 603 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 684 Cr (Quarterly Results - Mar 2025)<BR>- Market-cap value: INR 3,083 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 10.00<BR>- Industry P/E: 37<BR>- Dividend Yield: 2.08%<BR>- Debt-Equity: -0.02<BR>- Return on Equity: 13.28%<BR>- Price to Book: 1.32<BR><BR>Contact Details:<BR>Address: Alembic Road, Vadodara Gujarat: 390003<BR>Tel: 91-0265-2280550<BR>Email: alembic.investors@alembic.co.in<BR>Website: http://www.alembiclimited.com

View full answer

Who are the top shareholders of the Alembic?

17-Jul-2025

The top shareholders of Alembic include Nirayu Limited with 63.06%, 49 Foreign Institutional Investors holding 1.66%, and individual investors owning 21.94%. There are no mutual funds or public shareholders among the top holders.

The top shareholders of Alembic primarily consist of its promoters, with Nirayu Limited holding the largest stake at 63.06%. Additionally, there are 49 Foreign Institutional Investors (FIIs) who collectively hold 1.66% of the company. Individual investors also have a significant presence, owning 21.94% of the shares. Notably, there are no mutual funds currently invested in Alembic, and there are no public shareholders listed among the top holders.

View full answer

How big is Alembic?

24-Jul-2025

As of 24th July, Alembic Ltd has a market capitalization of 3,056.00 Cr, with recent net sales of 221.88 Cr and net profit of 310.68 Cr over the last four quarters.

As of 24th July, <BR><BR>Market Cap: Alembic Ltd has a market capitalization of 3,056.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 221.88 Cr, while the sum of Net Profit for the same period is 310.68 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 2,338.59 Cr and Total Assets totaling 2,503.00 Cr.

View full answer

How has been the historical performance of Alembic?

12-Nov-2025

Alembic has shown significant growth from March 2023 to March 2025, with net sales increasing from 127.24 Cr to 221.88 Cr, and profit after tax rising from 80.62 Cr to 144.57 Cr. The company also improved its operating profit margin to 42.23% and consolidated net profit to 310.68 Cr by March 2025.

Answer:<BR>The historical performance of Alembic shows significant growth in net sales and profitability over the years, particularly from March 2023 to March 2025.<BR><BR>Breakdown:<BR>Alembic's net sales have increased from 127.24 Cr in March 2023 to 221.88 Cr in March 2025, reflecting a strong upward trend. Total operating income has similarly risen, reaching 221.88 Cr in March 2025, up from 127.24 Cr in March 2023. The company's operating profit (PBDIT) has also shown substantial growth, climbing from 104.60 Cr in March 2023 to 168.60 Cr in March 2025, with an operating profit margin of 42.23% in March 2025, compared to 31.7% in March 2023. Profit before tax increased from 86.80 Cr in March 2023 to 155.51 Cr in March 2025, and profit after tax rose from 80.62 Cr to 144.57 Cr in the same period. The consolidated net profit reached 310.68 Cr in March 2025, up from 190.65 Cr in March 2023. On the balance sheet, total assets grew from 2,204.58 Cr in March 2023 to 2,503.00 Cr in March 2025, while total liabilities increased from 2,204.58 Cr to 2,503.00 Cr. Cash flow from operating activities improved significantly, rising to 86.00 Cr in March 2025 from 38.00 Cr in March 2023. Overall, Alembic has demonstrated a robust financial performance with increasing revenues, profits, and asset growth over the observed period.

View full answer

Is Alembic technically bullish or bearish?

02-Dec-2025

As of December 1, 2025, Alembic's technical trend is mildly bearish, with mixed signals from indicators like MACD, RSI, and Bollinger Bands suggesting a cautious outlook and short-term weakness.

As of 1 December 2025, the technical trend for Alembic has changed from bearish to mildly bearish. The current stance is mildly bearish overall, driven by mixed signals across various indicators. The MACD shows a mildly bullish trend on the weekly chart but is mildly bearish on the monthly chart. The RSI indicates a bullish signal on the monthly timeframe, while the weekly shows no signal. Bollinger Bands and KST are both mildly bearish on the weekly and monthly charts. Daily moving averages remain bearish, suggesting short-term weakness. Dow Theory indicates no trend in both weekly and monthly perspectives. Overall, the indicators reflect a cautious outlook with a slight bearish bias.

View full answer

Are Alembic Ltd latest results good or bad?

13-Feb-2026

Alembic Ltd's latest results show strong revenue growth with net sales up 28.35% to ₹74.34 crores, but net profit declined 8.04% year-on-year to ₹60.13 crores, and operating margins contracted significantly, indicating mixed performance and potential operational challenges. Investors should be cautious given the profit volatility and margin pressures.

Alembic Ltd's latest results present a mixed picture. On one hand, the company reported a significant increase in net sales, reaching ₹74.34 crores, which is a 28.35% year-on-year growth. This indicates strong revenue momentum and suggests potential project completions or revenue recognition in their real estate segment.<BR><BR>However, the consolidated net profit has shown a decline of 8.04% year-on-year, dropping to ₹60.13 crores. This decline is concerning, especially when considering the substantial sequential drop of 53.20% from the previous quarter, where the profit was ₹128.49 crores, largely influenced by exceptional other income in that quarter.<BR><BR>Additionally, the operating margin has contracted significantly to 36.91%, down from 45.58% in the same quarter last year, indicating pressure on operational efficiency. The company's return on equity (ROE) stands at 12.78%, which, while slightly above average, is still below the sector median, raising questions about capital productivity.<BR><BR>Overall, while the revenue growth is a positive sign, the profit volatility, margin compression, and operational challenges suggest that the results are not entirely favorable. Investors may need to approach the company's prospects with caution, considering both the growth potential and the underlying issues affecting profitability.

View full answer

Should I buy, sell or hold Alembic Ltd?

14-Feb-2026

Why is Alembic Ltd falling/rising?

14-Mar-2026

As of 13-Mar, Alembic Ltd's stock price is at Rs. 81.05, reflecting a 2.34% decline and a total drop of 9% over the last six days. The stock has underperformed against the Sensex and hit a new 52-week low, driven by poor financial results and negative investor sentiment.

As of 13-Mar, Alembic Ltd's stock price is falling, currently at Rs. 81.05, which reflects a decrease of Rs. 1.94 or 2.34%. The stock has been on a downward trend, having lost value for the last six consecutive days, resulting in a total decline of 9% during this period. Additionally, the stock hit a new 52-week low of Rs. 80.55 today, indicating significant bearish sentiment among investors.<BR><BR>The stock's performance over various time frames also highlights its struggles; it has underperformed the benchmark Sensex, with a 1-week decline of 7.01% compared to the Sensex's 5.52% drop, and a 1-month decline of 15.18% versus the Sensex's 9.76%. Year-to-date, Alembic Ltd has fallen by 19.80%, while the Sensex has only decreased by 12.50%. Over the past year, the stock has generated a return of -12.38%, contrasting sharply with the Sensex's positive return of 1.00%.<BR><BR>The company's recent financial results have contributed to this decline. The profit after tax (PAT) for the quarter ending December 25 fell by 8.0%, and the earnings per share (EPS) reached its lowest at Rs. 2.34. Furthermore, despite a healthy long-term growth in net sales and operating profit, the stock is perceived as having an expensive valuation with a price-to-book value of 0.8, which may deter potential investors.<BR><BR>Investor participation has seen a rise in delivery volume, which increased by 35.32% against the 5-day average, but this has not translated into positive price movement. The stock is trading below its moving averages across various time frames, indicating a bearish trend. The lack of investment from domestic mutual funds, which hold 0% of the company, suggests a lack of confidence in the stock's current valuation or business prospects.<BR><BR>Overall, the combination of poor recent financial performance, significant underperformance relative to benchmarks, and negative investor sentiment has led to the continued decline in Alembic Ltd's stock price.

View full answer

Why is Alembic Ltd falling/rising?

15-Mar-2026

As of 14-Mar, Alembic Ltd's stock price is declining, currently at Rs. 81.05, reflecting a 2.34% drop and a total decline of 9% over the past six days. The stock has underperformed significantly compared to the Sensex, with year-to-date and one-year declines of 19.80% and -12.38%, respectively, amid concerns over flat quarterly results and high valuation metrics.

As of 14-Mar, Alembic Ltd's stock price is falling, currently at Rs. 81.05, which reflects a decrease of Rs. 1.94 or 2.34%. The stock has been on a downward trend, having lost value for the past six consecutive days, resulting in a total decline of 9% during this period. Today, it reached a new 52-week low of Rs. 80.55, indicating significant selling pressure.<BR><BR>The stock's performance over various time frames shows a concerning trend, with a 1-week decline of 7.01% and a 1-month drop of 15.18%, both of which are worse than the benchmark Sensex. Year-to-date, the stock has decreased by 19.80%, compared to a 12.50% decline in the Sensex. Additionally, over the past year, Alembic Ltd has generated a return of -12.38%, which is significantly underperforming the market.<BR><BR>Factors contributing to the stock's decline include flat quarterly results, with a reported profit after tax (PAT) of Rs. 60.13 crore, down 8% year-over-year, and an earnings per share (EPS) of Rs. 2.34, the lowest recorded. The company's valuation appears expensive with a price-to-book value of 0.8, and the PEG ratio stands at 4.7, suggesting that the stock may not be a good value relative to its earnings growth.<BR><BR>Furthermore, despite a healthy long-term growth in net sales and operating profit, domestic mutual funds hold no stake in the company, which may indicate a lack of confidence in its current valuation or business prospects. The stock's performance has also been below par in both the long-term and near-term, further contributing to investor sentiment that is driving the price down.

View full answer

Why is Alembic Ltd falling/rising?

16-Mar-2026

As of 15-Mar, Alembic Ltd's stock price is at Rs. 81.05, having fallen for six consecutive days and reaching a 52-week low of Rs. 80.55. The stock has underperformed its sector and broader market, with significant declines in profit and earnings, leading to concerns about its valuation and future performance.

As of 15-Mar, Alembic Ltd's stock price is falling, currently at Rs. 81.05, reflecting a change of -1.94 (-2.34%). The stock has been on a downward trend, having lost value for the last six consecutive days, resulting in a total decline of 9% during this period. Today, it reached a new 52-week low of Rs. 80.55, indicating significant selling pressure.<BR><BR>In terms of performance, Alembic Ltd has underperformed its sector by 0.53% today and has shown a substantial decline over various time frames, including a 15.18% drop over the past month and a 19.80% decrease year-to-date. Comparatively, the broader market, represented by the Sensex, has also declined but at a lesser rate of 9.76% for the month and 12.50% year-to-date.<BR><BR>The company's recent financial results have contributed to the negative sentiment surrounding the stock. The profit after tax (PAT) for the last quarter fell by 8.0%, and the earnings per share (EPS) reached its lowest at Rs. 2.34. Despite a healthy growth rate in net sales and operating profit over the long term, the stock's performance has been disappointing, generating a return of -12.38% over the past year.<BR><BR>Additionally, the stock is trading below its moving averages across various periods, which typically signals weakness. The valuation metrics suggest that the stock is considered expensive relative to its peers, with a price-to-book value of 0.8 and a PEG ratio of 4.7, indicating that the stock may not be a favorable investment at its current price.<BR><BR>Furthermore, the lack of investment from domestic mutual funds, which hold 0% of the company, may indicate a lack of confidence in the stock's future performance. This combination of poor short-term results, underperformance relative to benchmarks, and high valuation concerns are key factors contributing to the decline in Alembic Ltd's stock price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Flat results in Dec 25

  • PAT(Q) At Rs 60.13 cr has Fallen at -8.0%
  • EPS(Q) Lowest at Rs 2.34
2

With ROE of 12.8, it has a Very Expensive valuation with a 0.8 Price to Book Value

3

Despite the size of the company, domestic mutual funds hold only 0% of the company

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Realty

stock-summary
Market cap

INR 2,050 Cr (Small Cap)

stock-summary
P/E

7.00

stock-summary
Industry P/E

32

stock-summary
Dividend Yield

3.08%

stock-summary
Debt Equity

-0.03

stock-summary
Return on Equity

12.78%

stock-summary
Price to Book

0.82

Revenue and Profits:
Net Sales:
74 Cr
(Quarterly Results - Dec 2025)
Net Profit:
60 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (3.08%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-22.0%
0%
-22.0%
6 Months
-26.18%
0%
-26.18%
1 Year
-13.89%
2.40%
-11.49%
2 Years
-3.14%
5.94%
2.8%
3 Years
30.94%
11.30%
42.24%
4 Years
-2.09%
11.22%
9.13%
5 Years
-20.07%
8.88%
-11.19%

Latest dividend: 2.4 per share ex-dividend date: Aug-05-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

13-Feb-2026 | Source : BSE

Please find enclose herewith newspaper cuttings related to advertisement published for Unaudited Financial Results of the Company for the quarter and nine months period ended on 31st December 2025.

Standalone And Consolidated Financial Results For The Quarter And Nine Months Period Ended 31St December 2025

12-Feb-2026 | Source : BSE

Please find attched herewith Standalone and Consolidated Unaudited Financial Results for the quarter and nine months period ended 31st December 2025 along with limited review report.

Board Meeting Outcome for Outcome Of The Board Meeting

12-Feb-2026 | Source : BSE

Please find attached herewith the outcome of the Board Meeting held on 12th February 2026.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alembic Ltd has declared 120% dividend, ex-date: 05 Aug 25

stock-summary
SPLITS

Alembic Ltd has announced 2:10 stock split, ex-date: 26 Sep 06

stock-summary
BONUS

Alembic Ltd has announced 1:1 bonus issue, ex-date: 27 Sep 13

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
33.76%
EBIT Growth (5y)
100.47%
EBIT to Interest (avg)
28.70
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.06
Tax Ratio
10.92%
Dividend Payout Ratio
19.84%
Pledged Shares
0
Institutional Holding
1.33%
ROCE (avg)
1.68%
ROE (avg)
11.41%

Valuation key factors

Factor
Value
P/E Ratio
7
Industry P/E
32
Price to Book Value
0.82
EV to EBIT
23.40
EV to EBITDA
20.57
EV to Capital Employed
0.82
EV to Sales
8.36
PEG Ratio
4.74
Dividend Yield
3.08%
ROCE (Latest)
3.47%
ROE (Latest)
12.78%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.0%)

FIIs

Held by 42 FIIs (1.28%)

Promoter with highest holding

Nirayu Private Limited (63.06%)

Highest Public shareholder

None

Individual Investors Holdings

22.23%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 28.35% vs 47.30% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -8.04% vs 6.50% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "74.34",
          "val2": "57.92",
          "chgp": "28.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27.44",
          "val2": "26.40",
          "chgp": "3.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.55",
          "val2": "0.69",
          "chgp": "-20.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "60.13",
          "val2": "65.39",
          "chgp": "-8.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.91%",
          "val2": "45.58%",
          "chgp": "-8.67%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 1.84% vs 50.03% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 7.52% vs 30.93% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "105.61",
          "val2": "103.70",
          "chgp": "1.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "42.83",
          "val2": "39.98",
          "chgp": "7.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.15",
          "val2": "1.16",
          "chgp": "-0.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "190.13",
          "val2": "176.84",
          "chgp": "7.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.55%",
          "val2": "38.55%",
          "chgp": "2.00%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 11.34% vs 49.04% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 3.32% vs 23.30% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "179.95",
          "val2": "161.62",
          "chgp": "11.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "70.27",
          "val2": "66.38",
          "chgp": "5.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "1.85",
          "chgp": "-8.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "250.26",
          "val2": "242.23",
          "chgp": "3.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "39.05%",
          "val2": "41.07%",
          "chgp": "-2.02%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 40.89% vs 23.77% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 15.66% vs 40.90% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "221.89",
          "val2": "157.49",
          "chgp": "40.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "93.71",
          "val2": "56.87",
          "chgp": "64.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.47",
          "val2": "1.11",
          "chgp": "122.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "310.68",
          "val2": "268.62",
          "chgp": "15.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "42.23%",
          "val2": "36.11%",
          "chgp": "6.12%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
74.34
57.92
28.35%
Operating Profit (PBDIT) excl Other Income
27.44
26.40
3.94%
Interest
0.55
0.69
-20.29%
Exceptional Items
0.00
0.00
Consolidate Net Profit
60.13
65.39
-8.04%
Operating Profit Margin (Excl OI)
36.91%
45.58%
-8.67%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 28.35% vs 47.30% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -8.04% vs 6.50% in Dec 2024

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
105.61
103.70
1.84%
Operating Profit (PBDIT) excl Other Income
42.83
39.98
7.13%
Interest
1.15
1.16
-0.86%
Exceptional Items
0.00
0.00
Consolidate Net Profit
190.13
176.84
7.52%
Operating Profit Margin (Excl OI)
40.55%
38.55%
2.00%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 1.84% vs 50.03% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 7.52% vs 30.93% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
179.95
161.62
11.34%
Operating Profit (PBDIT) excl Other Income
70.27
66.38
5.86%
Interest
1.70
1.85
-8.11%
Exceptional Items
0.00
0.00
Consolidate Net Profit
250.26
242.23
3.32%
Operating Profit Margin (Excl OI)
39.05%
41.07%
-2.02%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 11.34% vs 49.04% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 3.32% vs 23.30% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
221.89
157.49
40.89%
Operating Profit (PBDIT) excl Other Income
93.71
56.87
64.78%
Interest
2.47
1.11
122.52%
Exceptional Items
0.00
0.00
Consolidate Net Profit
310.68
268.62
15.66%
Operating Profit Margin (Excl OI)
42.23%
36.11%
6.12%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 40.89% vs 23.77% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 15.66% vs 40.90% in Mar 2024

stock-summaryCompany CV
About Alembic Ltd stock-summary
stock-summary
Alembic Ltd
Small Cap
Realty
Alembic Limited is one of the India's most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. The Company operates primarily in the manufacture of Bulk Drugs and Real Estate Business. The company manufacture pharmaceuticals and chemicals, bulk drugs (penicillin and other antibiotics) and formulations. It works manufacturing facilities at Vadodara in Gujarat and Solan in Himachal Pradesh.
Company Coordinates stock-summary
Company Details
Alembic Road , Vadodara Gujarat : 390003
stock-summary
Tel: 91-0265-2280550
stock-summary
alembic.investors@alembic.co.in
Registrar Details
Link Intime India Pvt Ltd., B-102 & B103, Shangrila Complex, First Floor, Opp: HDFC Bank, Near Radhakrishna Char Rasta, Akota, Vadodara